Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,262 | 3,246 | 2,483 | 2,464 | 5,784 |
| Marketable Securities | 15,177 | 2,359 | 5,273 | 8,083 | 933 |
| Receivables | 964 | 1,117 | 672 | 318 | 735 |
| TOTAL | $19,563 | $7,865 | $9,623 | $10,951 | $7,682 |
| Non-Current Assets | |||||
| PPE Net | 596 | 412 | 392 | 358 | 295 |
| Other Non-Current Assets | 861 | 1,136 | 1,408 | 26 | 24 |
| TOTAL | $1,457 | $1,548 | $1,800 | $384 | $319 |
| Total Assets | $21,020 | $9,413 | $11,423 | $11,335 | $8,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,791 | 3,935 | 2,101 | 686 | 597 |
| Accrued Expenses | 1,471 | 442 | 817 | 204 | 114 |
| TOTAL | $8,147 | $5,579 | $5,543 | $6,140 | $711 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,885 | 1,202 | 2,625 | 5,250 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,147 | $5,579 | $5,543 | $6,140 | $711 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,379 | 1,275 | 1,272 | 1,257 | 1,252 |
| Common Shares | 11 | 11 | 11 | 11 | 11 |
| Retained earnings | -85,464 | -82,373 | -80,075 | -80,351 | -77,948 |
| Other shareholders' equity | 4,391 | 0 | 0 | 0 | 0 |
| TOTAL | $12,873 | $3,834 | $5,880 | $5,195 | $7,290 |
| Total Liabilities And Equity | $21,020 | $9,413 | $11,423 | $11,335 | $8,001 |